Conversely, the mutp53-NRF2 interaction prevents NRF2 binding to other targets, such as NQO1 and HO-1, reported to induce cytotoxic effects in cancer cells, as demonstrated by their silencing that increases breast cancer cell survival and migration (Figure 3b) [90,91]. The gene discussed is NFE2L2; the disease is breast carcinoma.